Mildronate: cardioprotective action through carnitine-lowering effect.
about
Inhibition of Histone Demethylases by 4-Carboxy-2,2′-Bipyridyl CompoundsDevelopment and application of a fluoride-detection-based fluorescence assay for γ-butyrobetaine hydroxylaseInhibition of 2-oxoglutarate dependent oxygenasesFatty acid synthesis and oxidation in cumulus cells support oocyte maturation in bovineUPLC-MS/MS method for bioequivalence study of oral drugs of meldonium.Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease miceEfficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyStructure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae.Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila.Story behind meldonium-from pharmacology to performance enhancement: a narrative review.Fluoromethylated derivatives of carnitine biosynthesis intermediates--synthesis and applications.Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction.Cation-π Interactions Contribute to Substrate Recognition in γ-Butyrobetaine Hydroxylase Catalysis.Modulating carnitine levels by targeting its biosynthesis pathway - selective inhibition of γ-butyrobetaine hydroxylase.Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism.Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis.Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport.Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.Comparison of the substrate selectivity and biochemical properties of human and bacterial γ-butyrobetaine hydroxylase
P2860
Q27667281-54D42AB2-7911-4C60-96EB-45E1E8E03BB8Q28269483-AADB4306-6FA1-4CD6-A9E9-8D3604520B78Q28306956-0040244D-A3A4-4970-BD0B-4E9E8DEE8083Q33631932-8D3EF477-7B5B-4626-81D0-AF3C5DC82684Q34019294-DE878F69-BDE0-4E7D-87C6-620436EEB4BDQ34043669-9EA82A6D-E7AD-4EB8-9020-5E766B185A98Q34214868-964AF002-9B64-4659-ABA2-2DE659ACFDCCQ34387590-BEC55AB7-444B-4F8F-8DBF-EA341C3A8600Q34655419-8EC7C48E-3F8A-48CC-94D8-06EAB0E2795AQ34991930-5D89EF14-D9F7-445D-9118-3BC784A80B21Q35071386-6CB560AA-41A7-4D65-8AF9-BF1832AF32A3Q35695648-FAA3F022-7F2E-40AC-9D75-9D1802E51D90Q37963740-EE9FF7A1-B39D-486B-B67E-398D7B8D867BQ38743340-F18D2F65-DB59-43E1-8FB1-84A8D3AD10CCQ38910604-EC54A385-913E-4477-9262-37336F330B72Q39045890-74996568-0912-4B8A-B4E1-0AA67A2F0966Q41861087-A1832F2D-5A8D-440E-975F-A19107528880Q42012386-B62BAE1D-BE99-4281-B12A-8B441B801A85Q42128115-211E8E32-F6B7-46D2-9163-D7791D812B86Q43242725-312550E9-5901-4C30-A750-8D390B206489Q47916260-20F1794E-956B-448F-B7B9-EBB11A3B7D52Q51007182-0E13971C-9F92-4071-8A1F-B9259018B57FQ51428083-612E4F15-D194-4755-8CE5-EDB4A9BEF66BQ55235061-C3C66CA6-67C7-4E20-A124-7320B28C9AFFQ57808510-A96BD3ED-8165-4404-BAD2-1F4F033C08EF
P2860
Mildronate: cardioprotective action through carnitine-lowering effect.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mildronate: cardioprotective action through carnitine-lowering effect.
@ast
Mildronate: cardioprotective action through carnitine-lowering effect.
@en
Mildronate: cardioprotective action through carnitine-lowering effect.
@nl
type
label
Mildronate: cardioprotective action through carnitine-lowering effect.
@ast
Mildronate: cardioprotective action through carnitine-lowering effect.
@en
Mildronate: cardioprotective action through carnitine-lowering effect.
@nl
prefLabel
Mildronate: cardioprotective action through carnitine-lowering effect.
@ast
Mildronate: cardioprotective action through carnitine-lowering effect.
@en
Mildronate: cardioprotective action through carnitine-lowering effect.
@nl
P2093
P1476
Mildronate: cardioprotective action through carnitine-lowering effect.
@en
P2093
Edgars Liepinsh
Ivars Kalvinsh
Maija Dambrova
P304
P356
10.1016/S1050-1738(02)00175-5
P577
2002-08-01T00:00:00Z